GR871212B
(en )
1987-12-15
Therapeutic use of serotonin antagonist
GB9104598D0
(en )
1991-04-17
New use of 5 ht antagonists
GB8600783D0
(en )
1986-02-19
N-methyl-d-aspartate receptor antagonists
IL94963A0
(en )
1991-06-10
Use of polyamines as ionic-channel regulating agents
EP0488959A3
(en )
1992-08-05
New uses of competitive nmda receptor antagonists
GB8906168D0
(en )
1989-05-04
Therapeutic agents
GR900100015A
(en )
1991-06-07
Dosage form for acalcium antagonist supply
GB2192001B
(en )
1990-05-09
Melatonin antagonist
DK329289D0
(en )
1989-07-03
NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS
AU5627194A
(en )
1994-07-04
New use of 5-ht3 receptor antagonists
ZA903015B
(en )
1991-12-24
Therapeutic use of 5-ht3 receptor antagonists
ZA894097B
(en )
1990-06-27
Alpha-adrenergic receptor antagonists
IL104821A0
(en )
1993-06-10
Novel 5-ht3 receptor antagonist
ZA898936B
(en )
1991-07-31
Use of benzomorphanes for cytoprotection
GB8903740D0
(en )
1989-04-05
Therapeutic agents
GB8810509D0
(en )
1988-06-08
New use of dopamine receptor agonists
ZA893146B
(en )
1989-06-28
Therapeutic use of serotonin antagonists
IE881220L
(en )
1988-10-25
5-ht3 receptor antagonists
GB9104599D0
(en )
1991-04-17
New use of 5 ht antagonists
GB8905130D0
(en )
1989-04-19
Therapeutic agents
IE892801L
(en )
1990-03-01
Antagonists of 5-ht and 5-ht3 receptors
ZA9110088B
(en )
1992-11-25
New use of quisqualate receptor antagonists
ZA892737B
(en )
1990-04-25
Azabiocyclic compounds having 5-ht3 receptor antagonist activity
IE873198L
(en )
1988-05-27
Ó-adreno receptor antagonists
IE891742L
(en )
1989-12-01
Ó-adrenergic receptor antagonists